Breaking News, Collaborations & Alliances

Syngene Signs R&D Agreement with GSK

Syngene scientists to work with GSK to advance drug discovery in multiple therapeutic areas d

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Syngene International (www.syngeneintl.com), a global contract research services company, has formed a multiyear R&D agreement with GSK that will focus on accelerating the discovery of new drug candidates using Syngene’s discovery services platforms. As part of the agreement, Syngene will set-up a customized discovery research laboratory to support projects across several therapeutic areas. A team of Syngene scientists will work closely with GSK’s global R&D teams on disco...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters